share_log

Jefferies Downgrades Third Harmonic Bio to Hold, Lowers Price Target to $3.6

Jefferies Downgrades Third Harmonic Bio to Hold, Lowers Price Target to $3.6

杰富瑞将第三Harmonic Bio的评级下调至持有,将目标价下调至3.6美元
Benzinga Real-time News ·  2022/12/16 06:02

Jefferies analyst Akash Tewari downgrades Third Harmonic Bio (NASDAQ:THRD) from Buy to Hold and lowers the price target from $30 to $3.6.

杰富瑞分析师Akash Tewari将Third Harmonic Bio(纳斯达克:TRAD)的评级从买入下调至持有,并将目标价从30美元下调至3.6美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发